Tigecycline + vancomycin with aztreonam
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Skin Diseases, Infectious
Conditions
Skin Diseases, Infectious
Trial Timeline
Nov 1, 2002 → Dec 1, 2003
NCT ID
NCT00228410About Tigecycline + vancomycin with aztreonam
Tigecycline + vancomycin with aztreonam is a phase 3 stage product being developed by Pfizer for Skin Diseases, Infectious. The current trial status is completed. This product is registered under clinical trial identifier NCT00228410. Target conditions include Skin Diseases, Infectious.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00228410 | Phase 3 | Completed |
Competing Products
20 competing products in Skin Diseases, Infectious